BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 34731893)

  • 1. [The COVID-19 Pandemic as an Opportunity and Challenge for Registries in Health Services Research: Lessons Learned from the Lean European Open Survey on SARS-CoV-2 Infected Patients (LEOSS)].
    Pilgram L; Schons M; Jakob CEM; Claßen AY; Franke B; Tscharntke L; Schulze N; Fuhrmann S; Sauer G; de Miranda SMN; Prasser F; Stecher M; Vehreschild JJ
    Gesundheitswesen; 2021 Nov; 83(S 01):S45-S53. PubMed ID: 34731893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First results of the "Lean European Open Survey on SARS-CoV-2-Infected Patients (LEOSS)".
    Jakob CEM; Borgmann S; Duygu F; Behrends U; Hower M; Merle U; Friedrichs A; Tometten L; Hanses F; Jung N; Rieg S; Wille K; Grüner B; Klinker H; Gersbacher-Runge N; Hellwig K; Eberwein L; Dolff S; Rauschning D; von Bergwelt-Baildon M; Lanznaster J; Strauß R; Trauth J; de With K; Ruethrich M; Lueck C; Nattermann J; Tscharntke L; Pilgram L; Fuhrmann S; Classen A; Stecher M; Schons M; Spinner C; Vehreschild JJ
    Infection; 2021 Feb; 49(1):63-73. PubMed ID: 33001409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autopsy registry can facilitate COVID-19 research.
    von Stillfried S; Bülow RD; Röhrig R; Knüchel-Clarke R; Boor P;
    EMBO Mol Med; 2020 Aug; 12(8):e12885. PubMed ID: 32559338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disease severity in hospitalized COVID-19 patients: comparing routine surveillance with cohort data from the LEOSS study in 2020 in Germany.
    Koppe U; Schilling J; Stecher M; Rüthrich MM; Marquis A; Diercke M; Haselberger M; Koll CEM; Niebank M; Ruehe B; Borgmann S; Grabenhenrich L; Hellwig K; Pilgram L; Spinner CD; Paerisch T;
    BMC Infect Dis; 2023 Feb; 23(1):89. PubMed ID: 36765274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19 in cancer patients: clinical characteristics and outcome-an analysis of the LEOSS registry.
    Rüthrich MM; Giessen-Jung C; Borgmann S; Classen AY; Dolff S; Grüner B; Hanses F; Isberner N; Köhler P; Lanznaster J; Merle U; Nadalin S; Piepel C; Schneider J; Schons M; Strauss R; Tometten L; Vehreschild JJ; von Lilienfeld-Toal M; Beutel G; Wille K;
    Ann Hematol; 2021 Feb; 100(2):383-393. PubMed ID: 33159569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serial measurements in COVID-19-induced acute respiratory disease to unravel heterogeneity of the disease course: design of the Maastricht Intensive Care COVID cohort (MaastrICCht).
    Tas J; van Gassel RJJ; Heines SJH; Mulder MMG; Heijnen NFL; Acampo-de Jong MJ; Bels JLM; Bennis FC; Koelmann M; Groven RVM; Donkers MA; van Rosmalen F; Hermans BJM; Meex SJ; Mingels A; Bekers O; Savelkoul P; Oude Lashof AML; Wildberger J; Tijssen FH; Buhre W; Sels JEM; Ghossein-Doha C; Driessen RGH; Kubben PL; Janssen MLF; Nicolaes GAF; Strauch U; Geyik Z; Delnoij TSR; Walraven KHM; Stehouwer CD; Verbunt JAMCF; Van Mook WNKA; van Santen S; Schnabel RM; Aries MJH; van de Poll MCG; Bergmans D; van der Horst ICC; van Kuijk S; van Bussel BCT
    BMJ Open; 2020 Sep; 10(9):e040175. PubMed ID: 32994259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial.
    Cuadrado-Lavín A; Olmos JM; Cifrian JM; Gimenez T; Gandarillas MA; García-Saiz M; Rebollo MH; Martínez-Taboada V; López-Hoyos M; Fariñas MC; Crespo J
    Trials; 2020 Jun; 21(1):472. PubMed ID: 32493494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastrointestinal bleeding and endoscopic findings in critically and non-critically ill patients with corona virus disease 2019 (COVID-19): Results from Lean European Open Survey on SARS-CoV-2 (LEOSS) and COKA registries.
    Zellmer S; Hanses F; Muzalyova A; Classen J; Braun G; Piepel C; Erber J; Pilgram L; Walter L; Göpel S; Wille K; Hower M; Rüthrich MM; Rupp J; Degenhardt C; Voigt I; Borgmann S; Stecher M; Jakob C; Dhillon C; Messmann H; Ebigbo A; Römmele C;
    United European Gastroenterol J; 2021 Nov; 9(9):1081-1090. PubMed ID: 34655180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. National registry for patients with inflammatory rheumatic diseases (IRD) infected with SARS-CoV-2 in Germany (ReCoVery): a valuable mean to gain rapid and reliable knowledge of the clinical course of SARS-CoV-2 infections in patients with IRD.
    Hasseli R; Mueller-Ladner U; Schmeiser T; Hoyer BF; Krause A; Lorenz HM; Regierer AC; Richter JG; Strangfeld A; Voll RE; Pfeil A; Schulze-Koops H; Specker C
    RMD Open; 2020 Sep; 6(2):. PubMed ID: 32878994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specialized palliative care for hospitalized patients with SARS-CoV-2 infection: an analysis of the LEOSS registry.
    Schmidt-Hellerau K; Raichle C; Ruethrich MM; Vehreschild JJ; Lanznaster J; Nunes de Miranda SM; Bausewein C; Vehreschild MJGT; Koll CEM; Simon ST; Hellwig K; Jensen BO; Jung N;
    Infection; 2023 Aug; 51(4):1119-1126. PubMed ID: 36952127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and evaluation of a data anonymization pipeline to promote Open Science on COVID-19.
    Jakob CEM; Kohlmayer F; Meurers T; Vehreschild JJ; Prasser F
    Sci Data; 2020 Dec; 7(1):435. PubMed ID: 33303746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. THE VALUE OF A REGIONAL 'LIVING' COVID-19 REGISTRY AND THE CHALLENGES OF KEEPING IT ALIVE.
    Hanna J; Chen T; Portales-Castillo C; Said M; Bulnes R; Newhart D; Sienk L; Schantz K; Rozzi K; Alag K; Bress J; Lesho DO E
    Perspect Health Inf Manag; 2021; 18(3):1d. PubMed ID: 34858116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pregnancy and neonatal outcomes in COVID-19: study protocol for a global registry of women with suspected or confirmed SARS-CoV-2 infection in pregnancy and their neonates, understanding natural history to guide treatment and prevention.
    Banerjee J; Mullins E; Townson J; Playle R; Shaw C; Kirby N; Munnery K; Bourne T; Teoh TG; Dhanjal M; Poon L; Wright A; Lees C
    BMJ Open; 2021 Jan; 11(1):e041247. PubMed ID: 33514576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Status epilepticus during the COVID-19 pandemic in Cologne, Germany: data from a retrospective, multicentre registry.
    Kohle F; Madlener M; Bruno EF; Fink GR; Limmroth V; Burghaus L; Malter MP
    J Neurol; 2022 Nov; 269(11):5710-5719. PubMed ID: 35802201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19 mortality in cirrhosis is determined by cirrhosis-associated comorbidities and extrahepatic organ failure: Results from the multinational LEOSS registry.
    Brozat JF; Hanses F; Haelberger M; Stecher M; Dreher M; Tometten L; Ruethrich MM; Vehreschild JJ; Trautwein C; Borgmann S; Vehreschild MJGT; Jakob CEM; Stallmach A; Wille K; Hellwig K; Isberner N; Reuken PA; Geisler F; Nattermann J; Bruns T;
    United European Gastroenterol J; 2022 May; 10(4):409-424. PubMed ID: 35482663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use and effectiveness of remdesivir for the treatment of patients with covid-19 using data from the Lean European Open Survey on SARS-CoV-2 infected patients (LEOSS): a multicentre cohort study.
    Pilgram L; Appel KS; Ruethrich MM; Koll CEM; Vehreschild MJGT; de Miranda SMN; Hower M; Hellwig K; Hanses F; Wille K; Haselberger M; Spinner CD; Vom Dahl J; Hertenstein B; Westhoff T; Vehreschild JJ; Jensen BO; Stecher M
    Infection; 2023 Aug; 51(4):1033-1049. PubMed ID: 36763285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hospitalized patients dying with SARS-CoV-2 infection-An analysis of patient characteristics and management in ICU and general ward of the LEOSS registry.
    Raichle C; Borgmann S; Bausewein C; Rieg S; Jakob CEM; Simon ST; Tometten L; Vehreschild JJ; Leisse C; Erber J; Stecher M; Pauli B; Rüthrich MM; Pilgram L; Hanses F; Isberner N; Hower M; Degenhardt C; Hertenstein B; Vehreschild MJGT; Römmele C; Jung N;
    PLoS One; 2022; 17(7):e0271822. PubMed ID: 35905129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expert committees in German public health policymaking during the SARS-CoV-2 pandemic: a document analysis].
    Sell K; Saringer-Hamiti L; Geffert K; Strahwald B; Stratil JM; Pfadenhauer LM
    Z Evid Fortbild Qual Gesundhwes; 2021 Oct; 165():1-12. PubMed ID: 34474991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.